Loading...
L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy
The homing molecule, L-selectin (CD62L), is commonly used as a T cell activation marker, since expression is downregulated following engagement of the T cell receptor. Studies in mice have shown that CD62L(+) central memory T cells are better at controlling tumor growth than CD62L(−) effector memory...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582763/ https://ncbi.nlm.nih.gov/pubmed/31249570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01321 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|